Ausgabe 3/2012
Inhalt (13 Artikel)
Targeting Cytokine Signaling as an Innovative Therapeutic Approach for the Prevention of Atherosclerotic Plaque Development
Harald Schuett, Bernhard Schieffer
Clinical Trials of HDL Cholesterol–Raising Therapy: What Have We Learned About the HDL Hypothesis from AIM-HIGH?
Robert S. Rosenson
MicroRNAs as Biomarkers for Myocardial Infarction
Kanita Salic, Leon J. De Windt
Atherosclerosis, Inflammation, Genetics, and Stem Cells: 2012 Update
Pascal J. Goldschmidt-Clermont, Chunming Dong, David M. Seo, Omaida C. Velazquez
Sortilin as a Regulator of Lipoprotein Metabolism
Alanna Strong, Daniel J. Rader
Genetics of Thoracic Aortic Aneurysms
Guillaume Jondeau, Catherine Boileau
The Complex Genetic Basis of Plasma Triglycerides
Christopher T. Johansen, Robert A. Hegele
Genetics of Cholesterol Efflux
Iulia Iatan, Aurélien Palmyre, Sarah Alrasheed, Isabelle Ruel, Jacques Genest
Approaching the Asymptote: Obstacles and Opportunities for Nanomedicine in Cardiovascular Disease
Sascha N. Goonewardena
Molecular Pathways Regulating Macrophage Polarization: Implications for Atherosclerosis
Marten A. Hoeksema, J. Lauran Stöger, Menno P. J. de Winther
Mitochondrial Reactive Oxygen Species and Risk of Atherosclerosis
Maarten Hulsmans, Els Van Dooren, Paul Holvoet
Myeloperoxidase Production by Macrophage and Risk of Atherosclerosis
Mahir Karakas, Wolfgang Koenig
Liver X Receptors, Atherosclerosis and Inflammation
Daryn R. Michael, Tim G. Ashlin, Melanie L. Buckley, Dipak P. Ramji